Table 2.
Specific serum levels of IgG antibodies to EBNA-2(N) in sera from patients with different connective tissue diseases.1
| EBNA-2 | |||
|---|---|---|---|
| Diseases of patients groups (no. of specimens) | Median | Mann–Whitney test2 | |
| Systemic lupus erythematosus (102) | 0·084 | P < 0·0001 | |
| Primary Sjögrens's syndrome (74) | 0·070 | P = 0·0005 | |
| Rheumatoid arthritis (59) | 0·070 | P = 0·002 | |
| Systemic sclerosis (13) | 0·056 | n.s.3 | |
| Polyomyositis/dermatomyositis (7) | 0·042 | n.s. | |
| Mixed connective tissue disease (9) | 0·070 | n.s. | |
| Secondary SS associated with SLE (19) | 0·088 | P = 0·004 | |
| Secondary SS associated RA (23) | 0·075 | P = 0·002 | |
| Secondary SS associated with SSc (9) | 0·050 | n.s. | |
| Healthy control | 0·042 | ||
Specific serum levels of IgG antibodies to EBNA-2 were calculated by dividing ELISA OD450 readings by whole IgG protein concentrations.
P-values were calculated by comparing the medians of patient groups to that of normal healthy controls.
Not significant (n.s.).